Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06374901
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-04-15
Brief Title:
Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment
Sponsor:
Organization:
Zhejiang Cancer Hospital